126 related articles for article (PubMed ID: 37922570)
1. Identification and validation of INHBE and P4HA1 as hub genes in non-alcoholic fatty liver disease.
Cao J; Zhong Q; Huang Y; Zhu M; Wang Z; Xiong Z
Biochem Biophys Res Commun; 2023 Dec; 686():149180. PubMed ID: 37922570
[TBL] [Abstract][Full Text] [Related]
2. Identification of biomarkers for the diagnosis of chronic kidney disease (CKD) with non-alcoholic fatty liver disease (NAFLD) by bioinformatics analysis and machine learning.
Cao Y; Du Y; Jia W; Ding J; Yuan J; Zhang H; Zhang X; Tao K; Yang Z
Front Endocrinol (Lausanne); 2023; 14():1125829. PubMed ID: 36923221
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of potential diagnostic signature and immune cell infiltration for NAFLD based on cuproptosis-related genes by bioinformatics analysis and machine learning.
Ouyang G; Wu Z; Liu Z; Pan G; Wang Y; Liu J; Guo J; Liu T; Huang G; Zeng Y; Wei Z; He S; Yuan G
Front Immunol; 2023; 14():1251750. PubMed ID: 37822923
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of cuproptosis-related molecular clusters in non-alcoholic fatty liver disease.
Liu C; Fang Z; Yang K; Ji Y; Yu X; Guo Z; Dong Z; Zhu T; Liu C
J Cell Mol Med; 2024 Feb; 28(3):e18091. PubMed ID: 38169083
[TBL] [Abstract][Full Text] [Related]
5. Identification of ribosomal protein family as immune-cell-related biomarkers of NAFLD by bioinformatics and experimental analyses.
Li G; Li H; Chen Z
Front Endocrinol (Lausanne); 2023; 14():1161269. PubMed ID: 37274336
[TBL] [Abstract][Full Text] [Related]
6. Identification of metabolic biomarkers associated with nonalcoholic fatty liver disease.
Jiang H; Hu Y; Zhang Z; Chen X; Gao J
Lipids Health Dis; 2023 Sep; 22(1):150. PubMed ID: 37697333
[TBL] [Abstract][Full Text] [Related]
7. Integrated bioinformatics and machine-learning screening for immune-related genes in diagnosing non-alcoholic fatty liver disease with ischemic stroke and RRS1 pan-cancer analysis.
Bao H; Li J; Zhang B; Huang J; Su D; Liu L
Front Immunol; 2023; 14():1113634. PubMed ID: 37090698
[TBL] [Abstract][Full Text] [Related]
8. Identification of potential feature genes in non-alcoholic fatty liver disease using bioinformatics analysis and machine learning strategies.
Zhang Z; Wang S; Zhu Z; Nie B
Comput Biol Med; 2023 May; 157():106724. PubMed ID: 36898287
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of hub genes and molecular mechanisms in non-alcoholic steatohepatitis based on the gene expression omnibus database].
Li LY; Wu JX
Zhonghua Yi Xue Za Zhi; 2021 Nov; 101(40):3317-3322. PubMed ID: 34758532
[No Abstract] [Full Text] [Related]
10. Integrated Bioinformatics Analysis Identifies Robust Biomarkers and Its Correlation With Immune Microenvironment in Nonalcoholic Fatty Liver Disease.
Zhang F; Zhang Z; Li Y; Sun Y; Zhou X; Chen X; Sun S
Front Genet; 2022; 13():942153. PubMed ID: 35910194
[No Abstract] [Full Text] [Related]
11. Identification of hub genes and key pathways of dietary advanced glycation end products‑induced non‑alcoholic fatty liver disease by bioinformatics analysis and animal experiments.
Wang J; Liu H; Xie G; Cai W; Xu J
Mol Med Rep; 2020 Feb; 21(2):685-694. PubMed ID: 31974594
[TBL] [Abstract][Full Text] [Related]
12. Identification and Evaluation of Hub Long Noncoding RNAs and mRNAs in High Fat Diet Induced Liver Steatosis.
Sui J; Pan D; Yu J; Wang Y; Sun G; Xia H
Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839306
[TBL] [Abstract][Full Text] [Related]
13. Identification and validation of disulfidptosis-associated molecular clusters in non-alcoholic fatty liver disease.
Yu X; Guo Z; Fang Z; Yang K; Liu C; Dong Z; Liu C
Front Genet; 2023; 14():1251999. PubMed ID: 37745847
[No Abstract] [Full Text] [Related]
14. Bioinformatics analysis and machine learning approach applied to the identification of novel key genes involved in non-alcoholic fatty liver disease.
Nazari E; Khalili-Tanha G; Asadnia A; Pourali G; Maftooh M; Khazaei M; Nasiri M; Hassanian SM; Ghayour-Mobarhan M; Ferns GA; Kiani MA; Avan A
Sci Rep; 2023 Nov; 13(1):20489. PubMed ID: 37993474
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease.
Majdi A; Aoudjehane L; Ratziu V; Islam T; Afonso MB; Conti F; Mestiri T; Lagouge M; Foufelle F; Ballenghien F; Ledent T; Moldes M; Cadoret A; Fouassier L; Delaunay JL; Aït-Slimane T; Courtois G; Fève B; Scatton O; Prip-Buus C; Rodrigues CMP; Housset C; Gautheron J
J Hepatol; 2020 Apr; 72(4):627-635. PubMed ID: 31760070
[TBL] [Abstract][Full Text] [Related]
16. Identification and verification of diagnostic biomarkers in recurrent pregnancy loss via machine learning algorithm and WGCNA.
Wei C; Wei Y; Cheng J; Tan X; Zhou Z; Lin S; Pang L
Front Immunol; 2023; 14():1241816. PubMed ID: 37691920
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte vitamin D receptor regulates lipid metabolism and mediates experimental diet-induced steatosis.
Bozic M; Guzmán C; Benet M; Sánchez-Campos S; García-Monzón C; Gari E; Gatius S; Valdivielso JM; Jover R
J Hepatol; 2016 Oct; 65(4):748-757. PubMed ID: 27245430
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Analysis of NAFLD and the Therapeutic Target Identified.
Wen W; Wu P; Zhang Y; Chen Z; Sun J; Chen H
Front Cell Dev Biol; 2021; 9():704704. PubMed ID: 34616724
[No Abstract] [Full Text] [Related]
19. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Feng G; Li XP; Niu CY; Liu ML; Yan QQ; Fan LP; Li Y; Zhang KL; Gao J; Qian MR; He N; Mi M
Gene; 2020 Jun; 742():144549. PubMed ID: 32184169
[TBL] [Abstract][Full Text] [Related]
20. Heart failure with preserved ejection fraction and non-alcoholic fatty liver disease: new insights from bioinformatics.
Wang A; Li Z; Sun Z; Wang Y; Fu S; Zhang D; Ma X
ESC Heart Fail; 2023 Feb; 10(1):416-431. PubMed ID: 36266995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
